An intriguing case of cutaneous noduloulcerative lesion in the vicinity of genitalia.

100 Indian Journal of Sexually Transmitted Diseases and AIDS Volume 44, Issue 1, January-June 2023 2021;42:162‐5. 2. Kaur I, Dogra S, De D, Saikia UN. Histoid leprosy: A retrospective study of 40 cases from India. Br J Dermatol 2009;160:305‐10. 3. Chaudhury DS, Chaudhury M, Armah K. Histoid variety of lepromatous leprosy. Lepr Rev 1971;42:203‐7. 4. Bumb RA, Ghiya BC, Jakhar R, Prasad N. Histoid leprosy in an HIV positive patient taking cART. Lepr Rev 2010;81:221‐3. 5. Sivasankari M, Sinha P, Sunita BS, Awasthi S. A case of histoid leprosy presenting as immune reconstitution inflammatory syndrome (IRIS) in a patient of human immunodeficiency virus (HIV) infection on highly active retroviral therapy (HAART). Indian Dermatol Online J 2021;12:441‐3. 6. Vignesh R, Shankar EM. Thalidomide as a potential HIV latency reversal agent: Is it the right time to forget the ancestral sins? EBioMedicine 2017;24:20‐1. 7. Vergara TR, Samer S, Santos‐Oliveira JR, Giron LB, Arif MS, Silva‐Freitas ML, et al. Thalidomide is associated with increased T cell activation and inflammation in antiretroviral‐naive HIV‐infected individuals in a randomised clinical trial of efficacy and safety. EBioMedicine 2017;23:59‐67. How to cite this article: Hanumanthu V, Narang T, Dogra S, Kumar B. ”Lepromatous leprosy as a presenting feature of HIV:” Diagnostic and management dilemmas. Indian J Sex Transm Dis 2023;44:99-100.